My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Novo Nordisk A/S Common Stock (NY:NVO)

39.63 -7.79 (-16.43%)

Official Closing Price Updated: 4:10 PM EST, Feb 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Novo Nordisk A/S Common Stock

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

Why Novo Nordisk Stock Sank by Nearly 4% Today ↗

June 16, 2025

Via The Motley Fool

Ozempic Patent Expires In Canada After Novo Nordisk Fails To Pay $450 Fee: 'It's The Second-Largest Semaglutide Market In The World,' Says Sandoz CEO Richard Saynor ↗

June 16, 2025

A simple oversight could end up costing Danish pharma giant Novo Nordisk A/S (NYSE: NVO) billions in potential losses on its blockbuster weight-loss and diabetes drug, Ozempic.

Via Benzinga

Topics Intellectual Property

3 Growth Stocks You Can Buy Right Now Without Any Hesitation ↗

June 16, 2025

Via The Motley Fool

1 Growth Stock Down 9% to Buy Right Now ↗

June 14, 2025

Via The Motley Fool

Novo Nordisk Moves Amycretin Into Phase 3 Trials For Weight Management, Becomes Europe's Largest Company ↗

June 13, 2025

Novo Nordisk will begin phase 3 trials for amycretin in early 2026 following promising weight loss data and regulatory discussions.

Via Benzinga

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today ↗

June 13, 2025

Via Benzinga

Why Novo Nordisk Stock Pumped Higher on Thursday ↗

June 12, 2025

Via The Motley Fool

Novo Nordisk’s Plan To Start Late-Stage Trial Of Investigational Obesity Drug Amycretin In 2026 Gets Retail Talking ↗

June 12, 2025

The decision to advance the study of subcutaneous and oral Amycretin into the late stage is based on feedback received from regulators following mid-stage studies.

Via Stocktwits

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 12, 2025

Via Benzinga

Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills ↗

June 12, 2025

Nvidia teams up with Novo Nordisk and IQVIA to boost AI-powered drug development and streamline complex pharmaceutical workflows.

Via Benzinga

4 Dividend Stocks to Double Up on Right Now ↗

June 12, 2025

The stock market is a place where people tend to panic when things go on sale. Instead, buy the dip on these four fabulous dividend winners.

Via The Motley Fool

Topics Artificial Intelligence

2 Unstoppable Stocks to Consider Buying, Even Amid Market Volatility ↗

June 12, 2025

Via The Motley Fool

Topics Artificial Intelligence Government

Should You Buy UnitedHealth Stock Instead of Novo Nordisk Stock? ↗

June 12, 2025

Via The Motley Fool

McDonald's Just Got Hammered By Weight-Loss Drugs — Twice ↗

June 11, 2025

McDonald's faces a potential decline in sales due to the weight loss medications. Other fast-food chains like Domino's and KFC are also at risk, while Taco Bell and Chipotle are better positioned.

Via Benzinga

Nvidia Extends AI Reach In Europe With Alliances ↗

June 11, 2025

Nvidia announced a flurry of alliances with European companies and governments that extend its influence in AI across the continent.

Via Investor's Business Daily

Topics Artificial Intelligence Government

Novo Nordisk’s $812M Deal With Deep Apple Lifts Retail Mood, Chatter Spikes To High Levels ↗

June 11, 2025

Separately, chip-maker Nvidia also announced a collaboration with Novo Nordisk to accelerate drug discovery efforts through innovative AI use cases.

Via Stocktwits

Topics Artificial Intelligence Economy

Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies ↗

June 11, 2025

Novo Nordisk and Deep Apple ink a deal to develop oral therapies targeting a novel GPCR for cardiometabolic diseases, including obesity.

Via Benzinga

Why Novo Nordisk Stock Just Popped ↗

June 10, 2025

Novo Nordisk stock has multiple catalysts that could soon reverse is slide.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

June 10, 2025

Via Benzinga

2 Weight Loss Drug Stocks That Are Screaming Buys in June ↗

June 10, 2025

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing next-generation offerings.

Via The Motley Fool

Why Novo Nordisk Stock Eked Out a Win on Monday ↗

June 09, 2025

Via The Motley Fool

Obesity Newcomer Metsera, Up 23%, Enters The Ring With A Punch ↗

June 09, 2025

The company is planning to soon begin combination studies, testing two of its drugs in weight loss.

Via Investor's Business Daily

Topics Bankruptcy

Eli Lilly's Obesity Drug Success Spurs Japanese Biotech's Anti-Muscle-Wasting Combo Therapy ↗

June 09, 2025

Chugai plans to pair its muscle-preserving drug with Eli Lilly's orforglipron, addressing muscle loss in obesity care as the market expands rapidly.

Via Benzinga

Hims & Hers Stock Is Soaring Again. But Should You Buy the Stock? ↗

June 08, 2025

Via The Motley Fool

Topics Supply Chain

With Novo Nordisk's CEO Out, Wall Street Wants an American Leader

June 07, 2025

With its stock plummeting over the past year, Novo Nordisk is waving goodbye to its top executive. What might the future hold for the weight-loss drug kingpin?

Via MarketBeat

This Monster Growth Stock Is Up 167% in the Past Year and Disrupting the Healthcare Space ↗

June 07, 2025

Via The Motley Fool

Topics Intellectual Property

The Next Look At Amgen's Obesity Drug Is Coming. Here's What Investors Are Watching. ↗

June 06, 2025

Amgen is hoping to take on Eli Lilly and Novo Nordisk with a potential monthly shot, MariTide.

Via Investor's Business Daily

Novo Nordisk's Wegovy Tied To Increased Risk Of Rare Vision-Loss Disorder, European Regulators Say ↗

June 06, 2025

Semaglutide drugs now include rare vision risk warning as studies link long-term use to optic neuropathy, macular degeneration, and kidney cancer.

Via Benzinga

Novo Nordisk Stock: Is It Still a Smart Buy? ↗

June 06, 2025

Via The Motley Fool

Should You Invest $1,000 in Eli Lilly today? ↗

June 05, 2025

Via The Motley Fool

< Previous 1 2

...

24 25 26 27 28 29 30 31 32

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.